30: SOLV AFIB: A PREDICTION SCORE FOR NEW-ONSET POSTOPERATIVE ATRIAL FIBRILLATION AFTER CARDIAC SURGERYdoi:10.1097/01.ccm.0000508748.29266.f8Tran, DiemPerry, JeffreyDupuis, Jean-YvesWells, GeorgeCritical Care Medicine
Over the past 5 years, early diagnosis of and new treatments for cardiac amyloidosis (CA) have emerged that hold promise for early intervention. These include non-invasive diagnostic tests and disease modifying therapies. Recently, CA has been one of the first types of cardiomyopathy to be ...
In the past decade, there has been a concerted effort to explore pharmacological treatments for celiac disease. The endeavor is particularly challenging as a well-established, non-pharmacological therapy— the gluten-free diet—already exists. For a new drug to be a viable alternative, it must de...
especially in the post-operative period, and an excess of major bleeding for PRADAXA vs.warfarin. Use of PRADAXA for the prophylaxis of thromboembolic events in patients with AFib in the setting of other forms of valvular heart disease, including bioprosthetic...
Figure 1. Recent AFiBgCurGe 21. RinecheinbtiAtoBrCs:G2Kinoh1i4b3itor(sI:)K; os1m43a(lIl); smmoalllemcuolecsulebsabsaesded onn 1,14,64-,s6u-bssutbitustietduqteudinazo- quinazoline scaffoldlin(eIsIc)a, ff2o,l4d-(dIIis),u2b,4s-tdiitsuutbesdtitupteydripdyoripdyorpiymrimidiid...